Literature DB >> 25250477

Pregabalin for the treatment of painful hand-foot skin reaction associated with dabrafenib.

Evelyn Lilly1, Matthew Burke2, Harriet Kluger2, Jennifer Choi3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25250477     DOI： 10.1001/jamadermatol.2014.2455

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  5 in total

Review 1.  Cutaneous Complications of Targeted Melanoma Therapy.

Authors:  Emily de Golian; Bernice Y Kwong; Susan M Swetter; Silvina B Pugliese
Journal:  Curr Treat Options Oncol       Date:  2016-11

Review 2.  Regorafenib-associated hand-foot skin reaction: practical advice on diagnosis, prevention, and management.

Authors:  B McLellan; F Ciardiello; M E Lacouture; S Segaert; E Van Cutsem
Journal:  Ann Oncol       Date:  2015-06-01       Impact factor: 32.976

3.  Evaluating cost benefits of combination therapies for advanced melanoma.

Authors:  Ivar S Jensen; Emily Zacherle; Christopher M Blanchette; Jie Zhang; Wes Yin
Journal:  Drugs Context       Date:  2016-07-15

4.  Clinical study for external Chinese herbal medicine LC09 treating hand-foot skin reaction associated with the antitumor targeted drugs: Protocol for a prospective, randomized, controlled, double-blind, and monocentric clinical trial.

Authors:  Gui Wang; Liqun Jia; Yuying Pei; Ran Yu; Yu Gao; Chao Deng; Yanni Lou
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

Review 5.  Dermatologic conditions in women receiving systemic cancer therapy.

Authors:  Michelle N Ferreira; Julie Y Ramseier; Jonathan S Leventhal
Journal:  Int J Womens Dermatol       Date:  2019-11-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.